Distinguished 40 Year International Banker
and Former Ernst & Young Partner
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announced that Joseph (Jos) Luhukay has joined the Board of
Directors. Jos Luhukay joins Applied UV’s extensive Executive
leadership team and Board as the Company continues the global
market expansion of its patented, disruptive, and highly effective
suite of fixed and mobile air purification solutions (Airocide and
Scientific Air).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220524005294/en/
(Graphic: Business Wire)
Jos Luhukay is a seasoned international banking Executive with
over 40 years of experience leading many of Indonesia’s leading
financial institutions and a former Ernst and Young Partner who led
the business advisory and risk consulting practice which provided
services in corporate governance, risk management, information
systems audit and advisory, internal audit and policy and
operational process development. Jos Luhukay’s distinguished career
brings Applied UV a strong track record in delivering profitable
growth for internationally recognized bank and investment banking
companies including: Chief Operating Officer of Bank Niaga, Bahana
Pembinaan Usaha Indonesia, a main Indonesian Government-owned
investment Bank, Chief Operating Officer & Executive Director
of the Jakarta Initiative Task Force (set up by the Ministry of
Finance) where he managed a $65B portfolio and restructured over
20% of it in less than 2 years, President Director of Bank Lippo,
where he was awarded “CEO of the Year” in 2006 by SWA Magazine (the
largest business magazine in Indonesia), Deputy President of
Temasek-owned Bank Danamon and his most recent role as President
Director of Rabobank International Indonesia, a 30 year old Dutch
owned Commercial Bank in Indonesia. Jos Luhukay holds an
engineering degree in electrical engineering from the University of
Indonesia, a Master’s and PhD in Computer Science from the
University of Illinois at Urbana-Champaign.
John Andrews, Applied UV’s Chief Executive Officer, and Director
stated, “We welcome Jos to our Board of Directors. During his
distinguished career Jos has demonstrated a track record of
providing corporate governance, completing complex financial
execution and international regulatory compliance with financial
institutions that will complement and broaden our existing Board of
Directors. Jos’s international business connections throughout
Southeast Asia and Europe will prove valuable as we continue our
international expansion. Jos’s leadership and business acumen will
provide additional stewardship as we grow our globally recognized
suite of both fixed and mobile air purification solutions and is
another confident step we are undertaking, as we execute on our
global strategy.”
Jos Luhukay stated, “I am truly looking forward to working with
the leadership team in bringing forth our advanced air purification
technologies throughout the world. Both the health & medical
and waste-reduction in food production, transportation and storage
sectors will benefit highly from these technologies. Given the
global conditions we are in, Applied UV offers timely and highly
required solutions internationally.”
Both Monica Woo and Jos Luhukay were nominated by majority
shareholder and approved at Applied UV’s Annual Shareholder Meeting
held on May 17th, 2022, replacing Gene Bauer and Joel Kanter. On
May 17th, 2022, Alastair Clemow resigned from our Board.
Max Munn, Applied UV President and Director stated, “On behalf
of the entire Company, I’d like to thank Gene Bauer, Joel Kanter
and Alastair Clemow for their tireless efforts the past two years.
The stewardship and leadership they provided to our Board was
invaluable and has been instrumental in guiding the Company since
our IPO.”
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s Airocide® air
purification devices are research backed, clinically proven and
developed for NASA with assistance from the University of
Wisconsin. Airocide® is listed as an FDA Class II Medical device,
utilizes a proprietary photo catalytic (PCO) bioconversion
technology that draws air into a reaction chamber that converts
damaging molds, microorganisms, dangerous airborne pathogens,
destructive VOCs, allergens, odors and biological gasses into
harmless water vapor and green carbon dioxide without producing
ozone or other harmful byproducts. Airocide® applications include
healthcare, hospitality, grocery chains, wine making facilities,
commercial real estate, schools, dental offices, post-harvest,
grocery, cannabis facilities and homes. SteriLumen’s connected
platform for Data Driven Disinfection™ applies the power of
ultraviolet light (UVC) to destroy pathogens safely, thoroughly,
and automatically, addressing the challenge of healthcare-acquired
infections ("HAIs"). Targeted for use in facilities that have high
customer turnover such as hospitals, hotels, commercial facilities,
and other public spaces, the Company’s Lumicide™ platform uses UVC
LEDs in several patented designs for infection control in and
around high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive
location.
For more information about Applied UV, Inc., and its
subsidiaries, please visit the following website:
https://www.applieduvinc.com/
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward-looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220524005294/en/
For additional Company Information: Applied UV Inc. John
F. Andrews Applied UV Inc., CEO & Director
john.andrews@applieduvinc.com
Contact: Brett Maas, Managing Principal Hayden IR
brett@haydenir.com (646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Mar 2023 to Mar 2024